N4 Pharma PLC reports change in major holdings

Published 23/05/2025, 12:40
N4 Pharma PLC reports change in major holdings

LONDON - N4 Pharma PLC, a pharmaceutical company, has notified the market of a significant change in its major holdings. On April 23, 2025, Mathenz Marc Kay crossed a notable threshold in voting rights attached to the company’s shares.

According to the standard form for notification of major holdings, Mathenz Marc Kay now holds 8.89% of the voting rights in N4 Pharma PLC, which equates to 74,000,000 shares. This change represents a slight decrease from the previous notification, where the holding was reported at 9.12%.

The notification, completed in Singapore on May 23, 2025, also revealed that UOB Kay Hian Singapore Pte Ltd acts as the proxy holder for these voting rights, maintaining the same percentage of 8.89%.

The adjustment in shareholding has been disclosed in accordance with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority. It is a standard regulatory requirement for investors to inform a public company when their shareholding crosses certain percentage thresholds.

The London Stock Exchange (LON:LSEG)’s news service, RNS, reported this information, which is essential for investors and the market to track ownership and potential influence within publicly traded companies.

N4 Pharma PLC has not commented beyond the regulatory filing, and the reasons behind Mathenz Marc Kay’s adjustment in their stake have not been disclosed. The company continues to operate in the pharmaceutical sector, with this change in major holdings now a part of its investment landscape.

This notification is based on a press release statement and is intended to keep shareholders and the market informed of significant changes in share ownership.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.